Alanine aminotransferase (ALT) =< 3 x ULN
Serum alanine aminotransferase (ALT) < 2.5 x ULN
Alanine aminotransferase (ALT) =< 3.0 X ULN, within 14 days of registration
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT [SGPT]) ?2.5 × the ULN;
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 2 x ULN OR if hepatic involvement by lymphoma: ALT =< 5 x ULN
Alanine aminotransferase (ALT) < 2 x institutional ULN within 14 days of enrollment to trial
Alanine aminotransferase (ALT) =< 3.0 X ULN
alanine aminotransferase (ALT) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases
Alanine aminotransferase (ALT) =< 1.5 x institutional ULN
Within 14 days of the first dose of study drug: Alanine aminotransferase (ALT) =< 3 x ULN
Alanine aminotransferase (ALT) level =< 2.5 × ULN.
Alanine aminotransferase (ALT) < 3 x ULN, unless due to the underlying leukemia approved by the PI
Alanine aminotransferase (ALT) ? 3 x ULN for age, unless elevation is due to leukemic infiltration
Alanine aminotransferase (ALT) ? 3.0 x ULN (unless considered due to leukemic organ involvement)
Alanine aminotransferase (ALT) > 45 U/L
Alanine aminotransferase (ALT) =< 3 x ULN.
Alanine aminotransferase (ALT) level =< 2.5 x ULN
Alanine aminotransferase (ALT) ? 1.5 x ULN
alanine aminotransferase (ALT) <= 3.0 x ULN*
Alanine aminotransferase (ALT) =< 2.5 x ULN
To be performed within 14 days prior to day 1 of protocol therapy: alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 3 x ULN.
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 2.5 x ULN within 14 days of study registration.
Alanine aminotransferase (ALT) (SPGT) is ? 3 X ULN for age
Alanine aminotransferase (ALT) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 3 x ULN.
ALT (alanine aminotransferase) =< 2 x ULN
Alanine aminotransferase (ALT) =< 3 x ULN
Obtained within 14 days of randomization: Alanine aminotransferase (ALT) =< 3 x ULN
alanine aminotransferase (ALT) ? 3.0 × ULN*
Alanine aminotransferase (ALT) =< 2.5 x ULN prior to biopsy
Alanine aminotransferase (ALT) =< 2.5 x ULN
LYMPHODEPLETION: Alanine aminotransferase (ALT) =< 3.0 x ULN, obtained within 72 hrs prior to procurement
Within 14 days prior to planned start of treatment: Alanine aminotransferase (ALT) =< 2 x ULN
Alanine aminotransferase (ALT) =< 1.5 x ULN for the laboratory
Alanine aminotransferase (ALT) < 3 x ULN
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 3.0 x ULN
Alanine aminotransferase (ALT) < 1.5 x ULN
Alanine aminotransferase (ALT) =< 2 x ULN for the laboratory
Alanine transaminase (alanine aminotransferase [ALT]) > 3.0 x ULN
Alanine aminotransferase (ALT) =< 2.5 X ULN
Alanine aminotransferase (ALT) < 2.5 x ULN (3 x ULN for subjects on chronic anticonvulsive therapies known to increase transaminases).
Alanine aminotransferase (ALT) =< 3 x ULN for the laboratory, except in the presence of known hepatic metastasis, wherein the ALT may be =< 5 x ULN
Within 3 months of registration: Alanine aminotransferase (ALT) =< 2.5 x ULN
Within 14 days prior to study entry: Alanine aminotransferase (ALT) =< 3 x ULN
Alanine aminotransferase (ALT) =< 2.5 x ULN for the laboratory
Alanine aminotransferase (ALT) =< 3.5 x ULN
AT THE TIME OF INFUSION: Alanine aminotransferase (ALT) ? 5 x normal
Alanine aminotransferase (ALT) =< 2.5 x ULN
Within 2 weeks of enrollment: Alanine aminotransferase (ALT) =< 3 x normal range
Alanine aminotransferase (ALT) =< 189 IU/L
Alanine aminotransferase (ALT) =< 3 x ULN unless considered due to leukemic involvement
Alanine aminotransferase (ALT) =< 2 x ULN
Alanine aminotransferase (ALT) > 3 x ULN
Alanine aminotransferase (ALT) ?110 units per Liter (U/L). For the purpose of this study, the ULN for ALT is 45 U/L
Alanine aminotransferase (ALT) > 2.5 X ULN or cirrhosis
Alanine aminotransferase (ALT) within the reference range during screening evaluation
Alanine aminotransferase (ALT) > 5 x ULN
To be performed within 14 days prior to day 1 of protocol therapy: alanine aminotransferase (ALT) =< 3 x ULN\r\n* If hepatic involvement by lymphoma: ALT =< 5 x ULN
Within 14 days prior to day 1 of protocol therapy unless otherwise stated: Alanine aminotransferase (ALT) =< 2 x ULN
Alanine aminotransferase (ALT) =< 2.5 x ULN for the laboratory
Alanine aminotransferase (ALT) =< 3 x ULN
Alanine aminotransferase (ALT) < 1.5 X ULN; patients with Gilbert's disease are exempt from this criteria
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 3 x ULN for the laboratory
Alanine aminotransferase (ALT) =< 2.5 x ULN without, and =< 5 x ULN with hepatic metastasis
Alanine aminotransferase (ALT) ? 2 x ULN
Alanine aminotransferase (ALT) =< 3 x ULN within 14 days prior to study registration
Alanine aminotransferase (ALT) =< 2.5 x ULN without, and =< 5 x ULN with hepatic metastasis
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase less than or equal to 3 x ULN
Alanine aminotransferase (ALT) =< 3 x ULN
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 1.5 X ULN
Alanine aminotransferase (ALT) > 2.5 x ULN
and alanine aminotransferase (ALT) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases
alanine aminotransferase (ALT) less than or equal to 2.5 × ULN*
Alanine aminotransferase (ALT) ? 1.5 x ULN unless there is hepatic involvement, then 3 x ULN
Alanine aminotransferase (ALT) ? 5 × institutional ULN
Within 30 days prior to initiation of protocol treatment: Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 3 x ULN
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 1.5 x ULN
Alanine aminotransferase (ALT) < 5 x ULN age
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 1.5 x ULN
Alanine aminotransferase (ALT) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases
Alanine aminotransferase > 100 IU/L
Alanine aminotransferase (ALT) ?3 × ULN
Alanine aminotransferase (ALT) < 3 x ULN
Alanine aminotransferase (ALT) =< 2.5 x ULN (=< 5.0 x ULN if considered due to leukemic involvement)
Alanine aminotransferase (ALT) < 300 IU/ml
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 1.5 X ULN
Alanine aminotransferase (ALT) =< 2.5 x the ULN (in the absence of hepatic involvement of tumor)
Alanine aminotransferase (ALT) ?3xULN
Alanine aminotransferase (ALT) =< 5 x ULN for age, unless the elevation is disease-related
Alanine aminotransferase (ALT) =< 3 x ULN
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) > 3 x ULN for the laboratory
Serum alanine aminotransferase ? (ALT) 2.0 x ULN
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase (ALT) =< 1.8 X ULN
Alanine aminotransferase (ALT) =< 1.5 x ULN
Alanine aminotransferase (ALT) =< 2.5 x ULN
Alanine aminotransferase =< 40 IU/dL